OR WAIT 15 SECS
Starting with Eastern European sites in the 1990s, companies have increasingly selected investigator sites outside of North America and Western Europe.
Starting with Eastern European sites in the 1990s, companies have increasingly selected investigator sites outside of North America and Western Europe. Recently, drug development organizations have also been recruiting sites and enrolling patients in more remote locations such as Asia, India, and Latin America. Little research has been done on the attitudes of investigators in these newer geographies: why they participate in clinical trial research, what they like and dislike about their clinical trial experiences, and their thoughts about organizations conducting these clinical studies. TTC and the University of the Sciences in Philadelphia conducted a 4,000 multinational site survey.
The overall response distribution in Latin America closely followed the distribution of sites by country and therapeutic areas recorded in ClinicalTrials.gov. The complete questionnaire and respondent answers can be found online.
Latin America and US investigators emphasize the importance of medical innovation as grounds for their involvement in clinical studies. For Latin American physicians, this interest in innovation holds whether the research directly touches their patients or not. Latin American investigators are especially keen to share their clinical trial derived knowledge with other physicians.
—TTC and the University of Sciences in Philadelphia (for more information, contact firstname.lastname@example.org).